Given the known expansion of circulating CD27−CD21lo B cells in SjD and r‐axSpA patients and clonal relationships with both CD27+CD21lo B cells and early PBs, these cells might actively contribute to (pathological) immune responses in rheumatic diseases with autoimmune and/or autoinflammatory characteristics. The gene discussed is CD27; the disease is rheumatic disorder.